Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone

FEMS Immunology and Medical Microbiology

Volumn 38, Issue 1, 2003, Pages 13-22

  Beagley, Kenneth W ^a   Gockel, Christine M ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Estradiol; Immunoglobulin; Innate immunity; Lymphocyte; Progesterone; Uterus; Vagina

Indexed keywords

BETA DEFENSIN; CHEMOKINE; DEFENSIN; ESTRADIOL; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; PROGESTERONE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ALLOGRAFT; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BACTERIAL INFECTION; CELLULAR IMMUNITY; CHLAMYDIASIS; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOMETRIUM; ESCHERICHIA COLI; ESTRUS CYCLE; GENITAL TRACT INFECTION; GRANULOCYTE; HORMONE ACTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; MACROPHAGE; MEMORY CELL; MENSTRUAL CYCLE; METESTRUS; MONOCYTE; NATURAL KILLER CELL; NEISSERIA; NEUTROPHIL; NONHUMAN; ORAL CONTRACEPTION; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION; VAGINA EPITHELIUM; VAGINA SECRETION;

EID: 0142124417     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00202-5     Document Type: Short Survey

References (120)

1. Wira, C. and Kaushic, C. (1996) Mucosal immunity in the female reproductive tract: Effect of sex hormones on immune recognition and responses. In: Mucosal Vaccines: New Trends in Immunization (Kiyono, H., Ogra, P.L. and McGhee, J.R., Eds.), pp. 375-388. Academic Press, New York.
2. Wira, C.R., Kaushic, C. and Richardson, J. (1999) Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive trac. In: Mucosal Immunology (Ogra, P.L. et al., Eds.), pp. 1449-1461. Academic Press, San Diego, CA.
3. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
4. Takeda K., Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells. 6:2001;733-742.
5. Fichorova R.N., et al. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J. Immunol. 168:2002;2424-2432.
6. Gallo R.L., et al. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110:2002;823-831.
7. Lehrer R.I., Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:2002;96-102.
8. Quayle A.J., et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol. 152:1998;1247-1258.
9. Valore E.V., et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101:1998;1633-1642.
10. Cohen M.S., et al. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am. J. Obstet. Gynecol. 157:1987;1122-1125.
11. Walmer D.K., et al. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology. 131:1992;1458-1466.
12. Fahey J.V., Wira C.R. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J. Infect. Dis. 185:2002;1606-1613.
13. King A.E., Critchley H.O., Kelly R.W. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod. 6:2000;191-196.
14. Sonoda Y., et al. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J. Immunol. 160:1998;6159-6165.
15. Penny L.A. Monocyte chemoattractant protein 1 in luteolysis. Rev. Reprod. 5:2000;63-66.
16. Arici A., et al. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol. Reprod. 61:1999;85-90.
17. Boucher A., Lemay A., Akoum A. Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis. Fertil. Steril. 74:2000;969-975.
18. Petrovska M., Dimitrov D.G., Michael S.D. Quantitative changes in macrophage distribution in normal mouse ovary over the course of the estrous cycle examined with an image analysis system. Am. J. Reprod. Immunol. 36:1996;175-183.
19. De M., Wood G.W. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J. Endocrinol. 126:1990;417-424.
20. Kaushic C., et al. Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Am. J. Reprod. Immunol. 39:1998;209-216.
21. Reibiger I., Spanel-Borowski K. Difference in localization of eosinophils and mast cells in the bovine ovary. J. Reprod. Fertil. 118:2000;243-249.
22. Yang J.H., et al. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil. Steril. 74:2000;261-267.
23. Henderson T.A., et al. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 88:2003;440-449.
24. Verma S., et al. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 62:2000;959-968.
25. Ashkar A.A., Croy B.A. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin. Immunol. 13:2001;235-241.
26. Tokmadzic V.S., et al. IL-18 is present at the maternal-fetal interface and enhances cytotoxic activity of decidual lymphocytes. Am. J. Reprod. Immunol. 48:2002;191-200.
27. Croy B.A., et al. Decidual natural killer cells: key regulators of placental development (a review). J. Reprod. Immunol. 57:2002;151-168.
28. Okada H., et al. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 85:2000;4765-4770.
29. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2:2002;656-663.
30. Pijnenborg R. Implantation and immunology: maternal inflammatory and immune cellular responses to implantation and trophoblast invasion. Reprod. Biomed. Online. 4:2002;14-17.
31. Cuzzocrea S., et al. The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol. Med. 7:2001;478-487.
32. Ozveri E.S., et al. Estrogens ameliorate remote organ inflammation induced by burn injury in rats. Inflamm. Res. 50:2001;585-591.
33. Eckhoff D.E., et al. 17-Beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery. 132:2002;302-309.
34. Vegeto E., et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21:2001;1809-1818.
35. Medzhitov R., Janeway C.A.Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 296:2002;298-300.
36. Janeway C.A.Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
37. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
38. Prabhala R.H., Wira C.R. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J. Immunol. 155:1995;5566-5573.
39. Wira C.R., Rossoll R.M. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology. 84:1995;505-508.
40. Bebo B.F.Jr., et al. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162:1999;35-40.
41. Offner H., et al. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 105:2000;1465-1472.
42. Ito A., et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167:2001;542-552.
43. Liu H.Y., et al. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70:2002;238-248.
44. Fahey J.V., et al. Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in pre- and post-menopausal women. Am. J. Reprod. Immunol. 42:1999;49-57.
45. Wallace P.K., et al. MHC class II expression and antigen presentation by human endometrial cells. J. Steroid Biochem. Mol. Biol. 76:2001;203-211.
46. Wira C.R., Rossoll R.M. Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology. 136:1995;4526-4534.
47. Wira C.R., Rossoll R.M., Kaushic C. Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology. 141:2000;2877-2885.
48. Halliday G.M., Le S. Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int. Immunol. 13:2001;1147-1154.
49. Yarilin D., et al. Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis. Clin. Exp. Immunol. 127:2002;214-219.
50. Xu L.Y., Yang J.S., Xiao B.G. TGF-beta1-conditioned glial cell-derived dendritic cells inhibit expansion of MBP-reactive T cells in vitro. NeuroReport. 13:2002;35-39.
51. Takayama T., et al. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation. 74:2002;112-119.
52. Geissmann F., et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:1999;4567-4575.
53. Wira C.R., Roche M.A., Rossoll R.M. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology. 143:2002;2872-2879.
54. Nocera M., Chu T.M. Characterization of latent transforming growth factor-beta from human seminal plasma. Am. J. Reprod. Immunol. 33:1995;282-291.
55. Srivastava M.D., Lippes J., Srivastava B.I. Cytokines of the human reproductive tract. Am. J. Reprod. Immunol. 36:1996;157-166.
56. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182:2001;207-214.
57. Alpan O., Rudomen G., Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J. Immunol. 166:2001;4843-4852.
58. Yeaman G.R., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leukocyte Biol. 61:1997;427-435.
59. Yeaman G.R., et al. CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology. 102:2001;434-440.
60. Beagley K.W., et al. Characterization of murine uterine lymphoid aggregates. Mucosal Immunol. Update. 10:2002;3888.
61. White H.D., et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J. Immunol. 158:1997;3017-3027.
62. Laskarin G., et al. Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am. J. Reprod. Immunol. 42:1999;312-320.
63. Itohara S., et al. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature. 343:1990;754-757.
64. Penny L.A., et al. Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J. Reprod. Fertil. 115:1999;87-96.
65. Giron-Gonzalez J.A., et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur. J. Endocrinol. 143:2000;31-36.
66. Maret A., et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol. 33:2003;512-521.
67. Okuyama R., et al. Estrogen administration activates extrathymic T cell differentiation in the liver. J. Exp. Med. 175:1992;661-669.
68. McMurray R.W., et al. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine. 14:2001;324-333.
69. Fox H.S., Bond B.L., Parslow T.G. Estrogen regulates the IFN-gamma promoter. J. Immunol. 146:1991;4362-4367.
70. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158:1997;446-451.
71. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161:1998;3365-3374.
72. Cohen J.H., et al. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J. Immunol. 131:1983;2767-2771.
73. Stimson W.H. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand. J. Immunol. 28:1988;345-350.
74. Danel L., et al. Specific estrogen binding sites in human lymphoid cells and thymic cells. J. Steroid Biochem. 18:1983;559-563.
75. Zhao X.J., et al. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax. 56:2001;205-211.
76. Szekeres-Bartho J., et al. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell. Immunol. 125:1990;273-283.
77. Kutteh W.H., et al. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104:1996;538-542.
78. Kutteh, W.H. (1999) Mucosal immunity in the human female reproductive tract. In: Mucosal Immunology (Ogra, P.L. et al., Eds.), pp. 1423-1434. Academic Press, San Diego, CA.
79. Gallichan W.S., Rosenthal K.L. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology. 224:1996;487-497.
80. Nardelli-Haefliger D., et al. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J. Virol. 73:1999;9609-9613.
81. Wira C.R., Sandoe C.P. Hormonal regulation of immunoglobulins: influence of estradiol on immunoglobulins A and G in the rat uterus. Endocrinology. 106:1980;1020-1026.
82. Wira C.R., Sullivan D.A. Estradiol and progesterone regulation of immunoglobulin A and G and secretory component in cervicovaginal secretions of the rat. Biol. Reprod. 32:1985;90-95.
83. Wira C.R., Stern J.E., Colby E. Estradiol regulation of secretory component in the uterus of the rat: evidence for involvement of RNA synthesis. J. Immunol. 133:1984;2624-2628.
84. Murdoch A.J., Buckley C.H., Fox H. Hormonal control of the secretory immune system of the human uterine cervix. J. Reprod. Immunol. 4:1982;23-30.
85. Lu F.X., et al. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect. Immun. 67:1999;6321-6328.
86. Lu F.X., et al. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin. Exp. Immunol. 128:2002;10-20.
87. Paavonen T., Andersson L.C., Adlercreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 154:1981;1935-1945.
88. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J. Allergy Clin. Immunol. 103:1999;282-288.
89. Brabin L. Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression. AIDS Patient Care STDS. 16:2002;211-221.
90. Catterall R.D. Influence of gestogenic contraceptive pills on vaginal candidosis. Br. J. Vener. Dis. 47:1971;45-47.
91. Kita E., et al. Virulence of transparent and opaque colony types of Neisseria gonorrhoeae for the genital tract of mice. J. Med. Microbiol. 34:1991;355-362.
92. Baker D.A., Plotkin S.A. Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc. Soc. Exp. Biol. Med. 158:1978;131-134.
93. Webster K., Taylor A., Gaston K. Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J. Gen. Virol. 82:2001;201-213.
94. Furr P.M., Taylor-Robinson D. Oestradiol-induced infection of the genital tract of female mice by Mycoplasma hominis. J. Gen. Microbiol. 135:1989;2743-2749.
95. Furr P.M., Taylor-Robinson D. The establishment and persistence of Ureaplasma urealyticum in oestradiol-treated female mice. J. Med. Microbiol. 29:1989;111-114.
96. Furr P.M., Taylor-Robinson D. The contrasting effects of progesterone and oestrogen on the susceptibility of mice to genital infection with Mycoplasma pulmonis. J. Med. Microbiol. 38:1993;160-165.
97. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2002;2741-2751.
98. Kaushic C., et al. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect. Immun. 66:1998;893-898.
99. Kaushic C., et al. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 68:2000;4207-4216.
100. Johansson E.L., et al. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect. Immun. 66:1998;514-520.
101. Wunderlich F., et al. Testosterone impairs efficacy of protective vaccination against P. chabaudi malaria. Vaccine. 11:1993;1097-1099.
102. Gockel C.M., Bao S., Beagley K.W. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Mol. Immunol. 37:2000;537-544.
103. Eidinger D., Garrett T.J. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. Exp. Med. 136:1972;1098-1116.
104. Weinstein Y., Ran S., Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J. Immunol. 132:1984;656-661.
105. Amadori A., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1:1995;1279-1283.
106. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2:2002;777-780.
107. Nelson J.L., Ostensen M. Pregnancy and rheumatoid arthritis. Rheum. Dis. Clin. North Am. 23:1997;195-212.
108. Confavreux C., et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. New Engl. J. Med. 339:1998;285-291.
109. Petri M. Systemic lupus erythematosus and pregnancy. Rheum. Dis. Clin. North Am. 20:1994;87-118.
110. Jansson L., Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47:1998;290-301.
111. Dalal M., Kim S., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159:1997;3-6.
112. Lin H., et al. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151:1993;4562-4573.
113. Wegmann T.G., et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today. 14:1993;353-356.
114. Croy B.A. Where now for the Th1/Th2 paradigm of the gestational uterus? J. Reprod. Immunol. 51:2001;1-2.
115. Chaouat G. Innately moving away from the Th1/Th2 paradigm in pregnancy. Clin. Exp. Immunol. 131:2003;393-395.
116. Sacks G.P., Redman C.W., Sargent I.L. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin. Exp. Immunol. 131:2003;490-497.
117. Kanda N., Tsuchida T., Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 42:1999;328-337.
118. Bynoe M.S., Grimaldi C.M., Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. USA. 97:2000;2703-2708.
119. Grimaldi C.M., Michael D.J., Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:2001;1886-1890.
120. Gockel, C.M., Bao, S., Holland, M.K. and Beagley, K.W. (2003) Influence of the murine oestrus cycle on the induction of mucosal immunity. Am. J. Repr. Immunol. (in press).